SIBRAFIBAN

CAS 172927-65-0 MFCD08141863

化学结构图

172927-65-0
SMILES: C[C@H](NC(=O)C1C=CC(=CC=1)/C(/N)=N/O)C(=O)N1CCC(CC1)OCC(=O)OCC

化学属性

Mol. FormulaC20H28N4O6
Mol. Weight420.463

别名和识别编码

Chemical NameSIBRAFIBAN
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. B Wittke, et al. Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin. Br J Clin Pharmacol. 2000 Mar;49(3):231-9.
  • [3]. Jeffrey T Billheimer, et al. Effects of glycoprotein IIb/IIIa antagonists on platelet activation: development of a transfer method to mimic peak to trough receptor occupancy. Thromb Res. 2002 Sep 15;107(6):303-17.
  • [1]. M Dooley, et al. Sibrafiban. Drugs. 1999 Feb;57(2):225-30; discussion 231-2.
  • [1]. M Dooley, et al. Sibrafiban. Drugs. 1999 Feb;57(2):225-30; discussion 231-2.
  • [2]. B Wittke, et al. Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin. Br J Clin Pharmacol. 2000 Mar;49(3):231-9.
  • [3]. Jeffrey T Billheimer, et al. Effects of glycoprotein IIb/IIIa antagonists on platelet activation: development of a transfer method to mimic peak to trough receptor occupancy. Thromb Res. 2002 Sep 15;107(6):303-17.

系列性分类

  1. Medical Research Areas
  2. Cytosketetal Signaling
  3. Integrin  (整合素)

相关产品推荐